- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Scott Commins on Expanding Awareness of Food Allergy Manifestations to Other Specialists
There are greater awareness efforts taking place to educate other specialists on referring patients who are having suspected allergic reactions to the appropriate allergists, who can do a fuller evaluation, said Scott P. Commins, MD, PhD, associate professor of medicine, at the University of North Carolina.
There are greater awareness efforts taking place to educate other specialists on referring patients who are having suspected allergic reactions to the appropriate allergists, who can do a fuller evaluation, said Scott P. Commins, MD, PhD, associate professor of medicine, at the University of North Carolina.
Transcript
What efforts are taking place to educate other specialties, such as pediatricians, internists, emergency providers, and others, about best practices in food allergy prevention and treatment?
I think there’s a lot of awareness going on whether it’s through the Food Allergy Research and Education Group or even coming out through the allergy journals, but then equally trying to get awareness to physicians who are on the frontline whether it’s adult food allergy or childhood. Mainly with the idea of “If you suspect this is happening, it’s totally appropriate to refer these folks and don’t even necessarily need to do the evaluation in your office.” I think most allergists are more than pleased to do the full evaluation in their office, where we have the full capability to do skin testing, we’re proficient with the bloodwork, and it saves, often, confusion about this.
I think the other aspect of this is broadening the idea of what we kind of define of food allergy as. So, empowering our gastroenterologists or dermatologists to think about either belly pain or say, hives, respectively, as potential manifestations of food allergy. Go ahead and make that referral and [we’d] be happy to see those patients.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More
